Prevention and Treatment of Atherosclerosis : Improving State-of-the-Art Management and Search for Novel Targets / / edited by Arnold von Eckardstein, Christoph J. Binder.

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding in...

Full description

Saved in:
Bibliographic Details
Superior document:Handbook of Experimental Pharmacology, 270
:
TeilnehmendeR:
Place / Publishing House:Cham : : Springer International Publishing :, Imprint: Springer,, 2022.
Year of Publication:2022
Edition:1st ed. 2022.
Language:English
Series:Handbook of Experimental Pharmacology, 270
Physical Description:1 online resource (537 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993544793204498
ctrlnum (CKB)5670000000200408
(MiAaPQ)EBC6877842
(Au-PeEL)EBL6877842
(OCoLC)1295275583
(oapen)https://directory.doabooks.org/handle/20.500.12854/78275
(DE-He213)978-3-030-86076-9
(PPN)272258202
(EXLCZ)995670000000200408
collection bib_alma
record_format marc
spelling Eckardstein, Arnold von.
Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder.
1st ed. 2022.
Cham : Springer International Publishing : Imprint: Springer, 2022.
1 online resource (537 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Handbook of Experimental Pharmacology, 1865-0325 ; 270
English
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .
Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
Open Access
Internal medicine.
Pharmacology.
Diseases.
Internal Medicine.
Arterioesclerosi thub
Terapèutica thub
Medicina preventiva thub
Llibres electrònics thub
3-030-86075-2
Binder, Christoph J.
language English
format Electronic
eBook
author Eckardstein, Arnold von.
spellingShingle Eckardstein, Arnold von.
Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets /
Handbook of Experimental Pharmacology,
Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
author_facet Eckardstein, Arnold von.
Binder, Christoph J.
author_variant a v e av ave
author2 Binder, Christoph J.
author2_variant c j b cj cjb
author2_role TeilnehmendeR
author_sort Eckardstein, Arnold von.
title Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets /
title_sub Improving State-of-the-Art Management and Search for Novel Targets /
title_full Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder.
title_fullStr Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder.
title_full_unstemmed Prevention and Treatment of Atherosclerosis [electronic resource] : Improving State-of-the-Art Management and Search for Novel Targets / edited by Arnold von Eckardstein, Christoph J. Binder.
title_auth Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets /
title_new Prevention and Treatment of Atherosclerosis
title_sort prevention and treatment of atherosclerosis improving state-of-the-art management and search for novel targets /
series Handbook of Experimental Pharmacology,
series2 Handbook of Experimental Pharmacology,
publisher Springer International Publishing : Imprint: Springer,
publishDate 2022
physical 1 online resource (537 pages)
edition 1st ed. 2022.
contents Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
isbn 3-030-86076-0
3-030-86075-2
issn 1865-0325 ;
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC1-1245
callnumber-sort RC 11 41245
genre Llibres electrònics thub
genre_facet Llibres electrònics
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616
dewey-sort 3616
dewey-raw 616
dewey-search 616
oclc_num 1295275583
work_keys_str_mv AT eckardsteinarnoldvon preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets
AT binderchristophj preventionandtreatmentofatherosclerosisimprovingstateoftheartmanagementandsearchfornoveltargets
status_str n
ids_txt_mv (CKB)5670000000200408
(MiAaPQ)EBC6877842
(Au-PeEL)EBL6877842
(OCoLC)1295275583
(oapen)https://directory.doabooks.org/handle/20.500.12854/78275
(DE-He213)978-3-030-86076-9
(PPN)272258202
(EXLCZ)995670000000200408
carrierType_str_mv cr
hierarchy_parent_title Handbook of Experimental Pharmacology, 270
hierarchy_sequence 270
is_hierarchy_title Prevention and Treatment of Atherosclerosis Improving State-of-the-Art Management and Search for Novel Targets /
container_title Handbook of Experimental Pharmacology, 270
author2_original_writing_str_mv noLinkedField
_version_ 1797815017063579648
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03195nam a22006135i 4500</leader><controlfield tag="001">993544793204498</controlfield><controlfield tag="005">20240429155227.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#cnu||||||||</controlfield><controlfield tag="008">220131s2022 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-86076-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-86076-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5670000000200408</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6877842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6877842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1295275583</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/78275</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-86076-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PPN)272258202</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995670000000200408</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC1-1245</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED010000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJ</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Eckardstein, Arnold von.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevention and Treatment of Atherosclerosis</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Improving State-of-the-Art Management and Search for Novel Targets /</subfield><subfield code="c">edited by Arnold von Eckardstein, Christoph J. Binder.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (537 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Diet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Internal medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diseases.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Internal Medicine.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arterioesclerosi</subfield><subfield code="2">thub</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Terapèutica</subfield><subfield code="2">thub</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicina preventiva</subfield><subfield code="2">thub</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Llibres electrònics</subfield><subfield code="2">thub</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-86075-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Binder, Christoph J.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">270</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-05-01 02:50:03 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-02-12 19:07:41 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337700520004498&amp;Force_direct=true</subfield><subfield code="Z">5337700520004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337700520004498</subfield></datafield></record></collection>